project id: TCGA-LGG; case submitter id: TCGA-E1-A7YQ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 8.4; age at index: 58; days to birth: -21341; days to death: 1578; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1942; year of death: 2004; age at diagnosis: 21341; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4796; initial weight: 180.0; sample id: 0834a667-9692-43c9-8cd9-1dc222f658b9; sample submitter id: TCGA-E1-A7YQ-01A; portion id: c5119401-cd11-4e3d-b7d4-f45f685c0a0f; portion submitter id: TCGA-E1-A7YQ-01A-11; slide id: 559bd2a5-a0b7-42bd-9246-bc2331c0f7d5; slide submitter id: TCGA-E1-A7YQ-01A-01-TSA; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 90.0; section location: TOP;